Metabolic syndrome: review
DOI:
https://doi.org/10.12775/JEHS.2021.11.07.026Keywords
metabolic syndrome, insulin resistance, hypertonic disease, abdominal obesityAbstract
The psychosomatic component of the metabolic syndrome, historical aspect of the problem under study, physiological and biochemical mechanisms of pathogenesis are considered in the article. The symptomatic components of the metabolic syndrome and their interrelation are outlined, the ways of diagnosis and therapy and directions of modern research in this field are outlined.
References
Chaban O.S., Haustova O.O. (2004) Psyhosomatychna medytsyna [Psychosomatic medicine], Kyiv
Metabolichnyi syndrom [Metabolic syndrome] (2015) http://health-ua.com/article/19156-metabolichnij sindrom-she-odin-poglyad
Chasova I.Ye. (2003) Metabolicheskii sindrom. Kardiovaskuliarnaia terapiia s profilaktika [Metabolic syndrom. Cardiovascular therapy and prevention].
Bodnar P.M. (200) Metabolichnyi syndrom (oglyad literatury) [Metabolic syndrom (Review)]
Mankovskyi B.N. (2005)Metabolichnyi syndrom: rozpovsyudzhennist, diagnostyka, pryntsypy terapii [Metabolic syndrom: spread, diagnostics, therapy]
Eschwege E. Metabolic syndrome or insulin resistance syndrome. Recent epidemiological data / E.Eschwege, B.Balkau // Ann. Endocrinol. – 2003. – Vol. 64 (3 Suppl). – P. S32–S36.
Wilson P.W. Estimating cardiovascular disease risk and the metabolic syndrome: a Framingham view / P.W. Wilson // Endocrinol. Metab. Clin. North Am. – 2004. – Vol. 33 (3). – P. 467–481.
Mitchenko Ye.I. Metabolicheskii sindrom: sostoyanie problemi i lechebnie podhodi [Metabolic syndrome: current issue and therapeutic approaches] www.hippocard.com
Sokolova L.K. (2010) Metabolicheskii sindrom :klinika, kriterii diagnostiki, printsipi terapii [Metabolic syndrome: clinics, diagnostics criteria and therapy]
Haban P. Role of fasting serum C-peptide as a predictor of cardiovascular risk associated with the metabolic X-syndrome / Р. Haban, R. Simoncic, Е.Zidekova, L.Ozdin // Med. Sci. Monit. — 2002. — 8 (3).
Mitchenko O.I. (2011)Diagnostyka i likuvannya metabolichnogo syndromu, tsukrovoho diabetu, prediabetu i sertsevo-sudynnyh zahvoryuvan [Diagnostics and treatment of metabolic syndrome, diabetes, prediabetes and cardiovascular diseases]
Alberti K.G.M.M. Harmonizing the Metabolic Syndrome / Alberti K.G.M.M., Eckel R.H., Grundy S.M. et al. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity // Circulation. — 2009. — 120. — Р. 1640-1645.
Alberti G. Introduction to the metabolic syndrome / G. Alberti // Eur. Heart J. — 2005, Suppl. 7 (Supplement D). — D3-D5.
Despres J.-P. Metabolic syndrome: the dysmetabolic state of dysfunctional adipose tissue and insulin resistance / J.- P. Despres, H.B. Brewer // Eur.Heart J. — 2008, Suppl. 10 (Supplement B). — B1-B3.
Multimarker Approach to Evaluate the Incidence of the Metabolic Syndrome and Longitudinal Changes in Metabolic Risk Factors. The Framingham Offspring Study / Ingelsson E., Pencina M.J., Tofler G.H. et al. // Circulation. — 2007. — 116. — P. 984-992.
Franco O.H. Trajectories of Entering the Metabolic Syndrome. The Framingham Heart Study / Franco O.H., Massaro J.M., Civil J. et al. // Circulation. — 2009. — 120. — P. 1943-1950.
Sirenko Yu.M. (2010) Metabolichnyi syndrom u patsientiv z arterialnoyu hipertensiyeyu ta metabolichni efekty riznyh antyhipertensyvnyh preparativ [Metabolic syndrome of patients with arterial hypertension and metabolic effect of antihypertensive agents]
Mamedov M.N. (2006) Vozmozhni li diagnostika i lechenie metabolicheskogo sindroma v realnoi praktike? [ Is diagnostics and therapy available in routine medical practice?]
Organov R. (2007) Metabolicheskii sindrom: put ot nauchnoi kontseptsii do klinicheskogo diagnoza [Metabolic syndrome: from scientific concept to clinical diagnosis]
Chazova I.Ye. (2004) Metabolicheskii sindrom [Metabolic syndrome], Moskva
Mamedov M.N. (2006) Metabolicheskii sindrom – bolshe chem sochetanie faktorov riska: printsipi diagnostiki i lecheniya [Metabolic syndrome – more than risk factors combination: diagnostics and treatment], Moskva
Zadionchenko V.S. (2006) Arterialnaya hipertoniya pri metabolicheskom sindrome: patogenez, osnovi terapii [Arterial hypertension at metabolic syndrome: pathogenesis, basics of therapy]
Mamedov M.N. (2005) Algoritmi diagnostiki i lecheniya matabolicheskogo sindroma v kliniko-ambulatornih usloviyah [Strategies of metabolic syndrome diagnostics and treatment in hospitals]
Mitchenko O.I. ( 2008) Metabolicheskii sindrom, saharnii diabet, prediabetu i serdechno-sosudistie zabolevaniya [Metabolic syndrome, diabetes and cardiovascular diseases], Moskva
Tabas I. Anti-inflammatory therapy in chronic disease: Challenges and opportunities / I. Tabas, C. K. Glass // Science. – 2013. – Vol. 339. – P. 166–172.
Elbassuoni E. Better association of waist circumference with insulin resistance and some cardiovascular risk factors than body mass index / E. Elbassuoni // Endocrine Regulations. – 2013. – Vol. 47, N 1. – P. 3–14.
Carollo C. Wine consumption in the mediterranean diet: Old concepts in a new sight / C. Carollo, G. Caimi // Food Nutr. Sci. – 2012. – Vol. 3. – P. 1726–1733.
Noll С. Effect of red wine polyphenol dietary supplementation on two phase II enzymes in liver of hyperhomocysteinemic mice / C. Noll, J. Dairou, C. Ripoll [et al.] // Food and Chemical Toxicology. – 2011. – Vol. 49, N 8. – P. 1764–1769.
Velichko V.I. (2012) Novie podhodi v kompleksnom lechenii detei s ozhireniem [New approaches of complex treatment of overweighted children]
Schrieks I. C. Effect of red wine consumptionon biomarkers of oxidative stress / I. C. Schrieks, R. van den Berg, A. Sierksma [et al.] // Alcohol Alcohol. – 2013. – Vol. 48. – P. 153–159.
Chuang C. C. Potential mechanisms by which polyphenolrich grapes prevent obesity-mediated inflammation and metabolic diseases / C. C. Chuang, M. K. McIntosh // Ann. Rev. Nutr. – 2011. – Vol. 31. – P. 155–176.
Del Bas J. M. Grape seed procyanidins improve atherosclerotic risk index and induce liver CYP7A1 and SHP expression in healthy rats / J. M. Del Bas, J. Fernandez-Larrea, M. Blay [et al.] // FASEB J. – 2013. – Vol. 19. – P. 479–481.
Auger C. Red wine phenolic compounds reduce plasma lipids and apolipoprotein B and prevent early aortic atherosclerosis in hypercholesterolemic golden Syrian hamsters (Mesocricetus auratus) / C. Auger, B. Caporiccio, N. Landrault [et al.] // J Nutr. – 2002. – Vol. 132. – P. 1207–1213.
Perumalla A. V. S. Green tea and grape seed extracts — Potential applications in food safety and quality / A. V. S. Perumalla, N. S. Hettiarachchy // Food Res. Int. – 2011. – Vol. 44. – P. 827–839.
Zagayko A. L. Antioxidant complexes and lipoprotein metabolism — experience of grape extracts application under metabolic syndrome and neurogenic stress / A. L. Zagayko, A. B. Kravchenko, M. V. Voloshchenko, O. A. Krasilnikova // Lipoproteins — Role in Health and Diseases. – Croatia : InTech, 2012. – P. 445– 488.
Amarowitcz R. Biological Activity of Grapevine Phenolic Compounds / R. Amarowitcz, S. Weidner // Grapevine Molecular Physiology & Biotechnology ; ed. by K. A. RoubelakisAngelakis. – The Netherlands ; Dordrecht : Springer Science + Business Media, 2009. – P. 389–405.
Stepan V. Т., Fedoruk О. S., Badiuk N. S., Vasiuk V. L., Gozhenko А. І., Stepan B. T., Stepan N. A. Anti-dysbiotic and renoprotective action of plant remedies with metabolic syndrome / PharmacologyOnLine; Archives - 2021 - vol.1 – 96-105.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 M. Bobrova, S. Vorona, S. Koval, I. Savytskyi, Y. Merza, V. Savytskyi
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 410
Number of citations: 0
